Maintaining a Robust Clinical Trial Pipeline
The clinical research landscape is likely forever altered by the COVID-19 pandemic, especially regarding trial continuity and the potential for
sites
4 Key Integrations for Your Clinical Trial Management System
In this blog are some key CTMS integrations — using systems your institution has likely implemented — your team can use to streamline research operations.
Ideas for Managing Clinical Trial Finances Post-Pandemic
While the pandemic’s long-lasting effects on clinical trials are not yet fully known, effective financial management is a critical component
Key CTMS Capabilities to Improve Financial Management
A well-utilized CTMS streamlines financial workflows, automates participant payments, tracks budgets, and centralizes data, helping clinical sites maximize ROI and efficiency.
Why Institutions Should Consider an Externally Administered IBC
Clinical trials for gene therapy are booming, especially in the fields of oncology, infectious diseases, rare diseases, and regenerative medicine.
Site-Driven Metrics: Operational Data To Improve Research
The true value of metrics is to measure operational performance in order to improve internal processes. In clinical research, this is highly beneficial when applied where the work is conducted: at the sites.
Addressing Barriers to DEI in Clinical Research
Breaking down barriers to participation in clinical research has long been a challenge, affecting every aspect of the industry. As
Q&A from Remote Monitoring: Study Compliance In A Changing World
In a recent webinar, Advarra experts Emily Eldh and Ben Shankle provided insights and information in Remote Monitoring: Study Compliance
Regulatory Fine Points: What Research Sites Need to Do for Part 11 Compliance
To maintain Part 11 compliance, research sites must validate electronic systems storing FDA-regulated records, safeguarding data integrity and accuracy.
Building a Foundation for Regulatory Success in the Post-Pandemic Landscape
The past year has been one of the most challenging ever for those working in healthcare and clinical research. The
Q&A: FDA Inspections of Clinical Investigators: Understanding the Process and What to Expect
In a recent webinar, Advarra experts Constance Cullity and Michele Russell-Einhorn presented FDA Inspections of Clinical Investigators: Understanding the Process
Q&A Part II with Dr. Wendy Tate, Author of Insights Accrual Prediction Algorithm
This week, Advarra launched a pilot of the Insights Accrual Prediction platform to customers, powered by Wendy’s initial model and